A mechanistic overview on male infertility and germ cell cancers

Current Pharmaceutical Design

Volumn 10, Issue 5, 2004, Pages 449-469

  Crépieux, Pascale ^a   Lécureuil, Charlotte ^a   Marion, Sébastien ^a   Kara, Elodie ^a   Piketty, Vincent ^a   Martinat, Nadine ^a   Guillou, Florian ^a   Royère, Dominique ^a   Reiter, Eric ^a,b  

^a UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cancer; Human; Infertility; Reproduction; Testis

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CISPLATIN; CYTOTOXIC AGENT; DNA; EARLY GROWTH RESPONSE FACTOR 1; EPIDERMAL GROWTH FACTOR; ETOPOSIDE; FOLLITROPIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; IMATINIB; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROLACTIN; PROTEIN BCL 2; PROTEIN P53; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RNA BINDING PROTEIN; SEX HORMONE; SMAD1 PROTEIN; SMAD5 PROTEIN; STAT PROTEIN; STI 576; TELOMERASE; TRASTUZUMAB; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; BLOOD TESTIS BARRIER; BREAST CANCER; CANCER GENETICS; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; DNA REPAIR; ENZYME INHIBITION; GENE TARGETING; GENETIC ENGINEERING; GERM CELL TUMOR; HAPLOIDY; HEREDITY; HUMAN; IN VIVO STUDY; MALE; MALE INFERTILITY; MEIOSIS; MITOSIS; MOUSE; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; REVIEW; SEMINOMA; SIGNAL TRANSDUCTION; SPERMATOGENESIS; SRY GENE; STEROIDOGENESIS; TESTIS CARCINOMA;

ANIMALS; GERM CELLS; HUMANS; INFERTILITY, MALE; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS;

EID: 1042280307     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612043453270     Document Type: Review

References (256)

1. de Kretser DM, Baker HW. Infertility in men: recent advances and continuing controversies. J Clin Endocrinol Metab 1999; 84(10): 3443-3450.
2. Winston RM, Hardy K. Are we ignoring potential dangers of in vitro fertilization and related treatments? Nat Cell Biol 2002; 4(Suppl): s14-18.
3. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. BMJ 1992; 305(6854): 609-613.
4. Moller H, Skakkebaek NE. Risk of testicular cancer in subfertile men: case-control study. BMJ 1999; 318(7183): 559-562.
5. Sharpe RM. The physiology of reproduction. Raven, New-York, 2nd Edn. 1994; 1363-1434.
6. Pelletier RM, Byers SW. The blood-testis barrier and Sertoli cell junctions: structural considerations. Microsc Res Tech 1992; 20(1): 3-33.
7. Griswold MD. The central role of Sertoli cells in spermatogenesis. Semin Cell Dev Biol 1998; 9(4): 411-416.
8. Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 2000; 21(5): 551-583.
9. Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R. Male development of chromosomally female mice transgenic for Sry. Nature 1991; 351(6322): 117-121.
10. Ginsburg M, Snow MH, McLaren A. Primordial germ cells in the mouse embryo during gastrulation. Development 1990; 110(2): 521-528.
11. Yoshimizu T, Obinata M, Matsui Y. Stage-specific tissue and cell interactions play key roles in mouse germ cell specification. Development 2001; 128(4): 481-490.
12. Ying Y, Qi X, Zhao GQ. Induction of primordial germ cells from murine epiblasts by synergistic action of BMP4 and BMP8B signaling pathways. Proc Natl Acad Sci USA 2001; 98(14): 7858-7862.
13. Lawson KA, Dunn NR, Roelen BA, Zeinstra LM, Davis AM, Wright CV, et al. Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev 1999; 13(4): 424-436.
14. Ying Y, Liu XM, Marble A, Lawson KA, Zhao GQ. Requirement of Bmp8b for the generation of primordial germ cells in the mouse. Mol Endocrinol 2000; 14(7): 1053-1063.
15. Ying Y, Zhao GQ. Cooperation of endoderm-derived BMP2 and extraembryonic ectoderm-derived BMP4 in primordial germ cell generation in the mouse. Dev Biol 2001; 232(2): 484-492.
16. Kierszenbaum AL, Tres LL. Primordial germ cell-somatic cell partnership: a balancing cell signaling act. Mol Reprod Dev 2001; 60(3): 277-280.
17. Tremblay KD, Dunn NR, Robertson EJ. Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 2001; 128(18): 3609-3621.
18. Chang H, Matzuk MM. Smad5 is required for mouse primordial germ cell development. Mech Dev 2001; 104(1-2): 61-67.
19. Fujiwara T, Dunn NR, Hogan BL. Bone morphogenetic protein 4 in the extraembryonic mesoderm is required for allantois development and the localization and survival of primordial germ cells in the mouse. Proc Natl Acad Sci USA 2001; 98(24): 13739-13744.
20. Saitou M, Barton SC, Surani MA. A molecular programme for the specification of germ cell fate in mice. Nature 2002; 418(6895): 293-300.
21. Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 1988; 335(6185): 88-89.
22. Geissler EN, Ryan MA, Housman DE. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 1988; 55(1): 185-192.
23. Mintz B, Russell, ES. Gene-induced embryological modifications of primordial germ cells in the mouse. J Exp Zool 1957; 134: 207-237.
24. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, et al. Stem cell factor is encoded at the S1 locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990; 63(1): 213-224.
25. Manova K, Bachvarova RF. Expression of c-kit encoded at the W locus of mice in developing embryonic germ cells and presumptive melanoblasts. Dev Biol 1991; 146(2): 312-324.
26. Besmer P, Manova K, Duttlinger R, Huang EJ, Packer A, Gyssler C, et al, The kit-ligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis. Dev Suppl 1993: 125-137.
27. Toyoda-Ohno H, Obinata M, Matsui Y. Members of the ErbB receptor tyrosine kinases are involved in germ cell development in fetal mouse gonads. Dev Biol 1999; 215(2): 399-406.
28. Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche. Nature 2001; 414(6859): 98-104.
29. Lin H. The stem-cell niche theory: lessons from flies. Nat Rev Genet 2002; 3(12): 931-940.
30. Zhao GQ, Garbers DL. Male germ cell specification and differentiation. Dev Cell 2002; 2(5): 537-547.
31. Hombria JC, Brown S. The fertile field of Drosophila Jak/STAT signalling. Curr Biol 2002; 12(16): R569-575.
32. Kiger AA, Jones DL, Schulz C, Rogers MB, Fuller MT. Stem cell self-renewal specified by JAK-STAT activation in response to a support cell cue. Science 2001; 294(5551): 2542-2545.
33. Tulina N, Matunis E. Control of stem cell self-renewal in Drosophila spermatogenesis by JAK-STAT signaling. Science 2001; 294(5551): 2546-2549.
34. Kiger AA, White-Cooper H, Fuller MT. Somatic support cells restrict germline stem cell self-renewal and promote differentiation. Nature 2000; 407(6805): 750-754.
35. Forbes A, Lehmann R. Nanos and Pumilio have critical roles in the development and function of Drosophila germline stem cells. Development 1998; 125(4): 679-690.
36. Jaruzelska J, Kotecki M, Kusz K, Spik A, Firpo M, Reijo Pera RA. Conservation of a Pumilio-Nanos complex from Drosophila germ plasm to human germ cells. Dev Genes Evol 2003; 213(3): 120-126.
37. Moore FL, Jaruzelska J, Fox MS, Urano J, Firpo MT, Turek PJ, et al. Human Pumilio-2 is expressed in embryonic stem cells and germ cells and interacts with DAZ (Deleted in AZoospermia) and DAZ-like proteins. Proc Natl Acad Sci USA 2003; 100(2): 538-543.
38. Yen PH, Chai NN, Salido EC. The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. Hum Mol Genet 1996; 5(12): 2013-2017.
39. Houston DW, King ML. A critical role for Xdazl, a germ plasm-localized RNA, in the differentiation of primordial germ cells in Xenopus. Development 2000; 127(3): 447-456.
40. Pellas TC, Ramachandran B, Duncan M, Pan SS, Marone M, Chada K. Germ-cell deficient (gcd), an insertional mutation manifested as infertility in transgenic mice. Proc Natl Acad Sci USA 1991; 88(19): 8787-8791.
41. Beck AR, Miller IJ, Anderson P, Streuli M. RNA-binding protein TIAR is essential for primordial germ cell development. Proc Natl Acad Sci USA 1998; 95(5): 2331-2336.
42. Agulnik AI, Lu B, Zhu Q, Truong C, Ty MT, Arango N, et al. A novel gene, Pog, is necessary for primordial germ cell proliferation in the mouse and underlies the germ cell deficient mutation, gcd. Hum Mol Genet 2002; 11 (24): 3047-3053.
43. Lu B, Bishop CE. Mouse GGN1 and GGN3, two germ cell specific proteins from the single gene Ggn, interact with mouse POG and play a role in spermatogenesis. J Biol Chem 2003; 278(18): 16289-16296.
44. Linder P, Lasko PF, Ashburner M, Leroy P, Nielsen PJ, Nishi K, et al. Birth of the D-E-A-D box. Nature 1989; 337(6203): 121-122.
45. Tanaka SS, Toyooka Y, Akasu R, Katoh-Fukui Y, Nakahara Y, Suzuki R, et al. The mouse homolog of Drosophila Vasa is required for the development of male germ cells. Genes Dev 2000; 14(7): 841-853.
46. Rongo C, Lehmann R. Regulated synthesis, transport and assembly of the Drosophila germ plasm. Trends Genet 1996; 12(3): 102-109.
47. D'Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 2003; 3(1): 23-34.
48. Nadler JJ, Braun RE. Fanconi anemia complementation group C is required for proliferation of murine primordial germ cells. Genesis 2000; 27(3): 117-123.
49. Cheng NC, van de Vrugt HJ, van der Valk MA, Oostra AB, Krimpenfort P, de Vries Y, et al. Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Hum Mol Genet 2000; 9(12): 1805-1811
50. Koomen M, Cheng NC, van de Vrugt HJ, Godthelp BC, van der Valk MA, Oostra AB, et al. Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice. Hum Mol Genet 2002; 11(3): 273-281.
51. Atchison FW, Capel B, Means AR. Pin1 regulates the timing of mammalian primordial germ cell proliferation. Development 2003; 130(15): 3579-3586.
52. Orwig KE, Ryu BY, Avarbock MR, Brinster RL. Male germ-line stem cell potential is predicted by morphology of cells in neonatal rat testes. Proc Natl Acad Sci USA 2002; 99(18): 11706-11711.
53. Coucouvanis EC, Jones PP. Changes in protooncogene expression correlated with general and sex-specific differentiation in murine primordial germ cells. Mech Dev 1993; 42(1-2): 49-58.
54. Godin I, Deed R, Cooke J, Zsebo K, Dexter M, Wylie CC. Effects of the steel gene product on mouse primordial germ cells in culture. Nature 1991; 352(6338): 807-809.
55. Matsui Y, Zsebo K, Hogan BL. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 1992; 70(5): 841-847.
56. Pesce M, Farrace MG, Piacentini M, Dolci S, De Felici M. Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). Development 1993; 118(4): 1089-1094.
57. Felici MD, Carlo AD, Pesce M, Iona S, Farrace MG, Piacentini M. Bcl-2 and Bax regulation of apoptosis in germ cells during prenatal oogenesis in the mouse embryo. Cell Death Differ 1999; 6(9): 908-915.
58. Rucker EB 3rd, Dierisseau P, Wagner KU, Garrett L, Wynshaw-Boris A, Flaws JA, et al. Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis. Mol Endocrinol 2000; 14(7): 1038-1052.
59. Modi DN, Sane S, Bhartiya D. Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads. Mol Hum Reprod 2003; 9(4): 219-225.
60. de Rooij DG. Proliferation and differentiation of spermatogonial stem cells. Reproduction 2001; 121(3): 347-354.
61. Wolfes H, Kogawa K, Millette CF, Cooper GM. Specific expression of nuclear proto-oncogenes before entry into meiotic prophase of spermatogenesis. Science 1989; 245(4919): 740-743.
62. Schrans-Stassen BH, Saunders PT, Cooke HJ, de Rooij DG. Nature of the spermatogenic arrest in Dazl -/- mice. Biol Reprod 2001; 65(3): 771-776.
63. de Rooij DG, Okabe M, Nishimune Y. Arrest of spermatogonial differentiation in jsd/jsd, S117H/S117H, and cryptorchid mice. Biol Reprod 1999; 61(3): 842-847.
64. Rossi P, Dolci S, Sette C, Geremia R. Molecular mechanisms utilized by alternative c-kit gene products in the control of spermatogonial proliferation and sperm-mediated egg activation. Andrologia 2003; 35(1): 71-78.
65. Ohta H, Yomogida K, Dohmae K, Nishimune Y. Regulation of proliferation and differentiation in spermatogonial stem cells: the role of c-kit and its ligand SCF. Development 2000; 127(10): 2125-2131.
66. Guerif F, Cadoret V, Rahal-Perola V, Lansac J, Bernex F, Jacques Panthier J, et al. Apoptosis, onset and maintenance of spermatogenesis: evidence for the involvement of Kit in Kit-haplodeficient mice. Biol Reprod 2002; 67(1): 70-79.
67. Blume-Jensen P, Jiang G, Hyman R, Lee KF, O'Gorman S, Hunter T. Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility. Nat Genet 2000; 24(2): 157-162.
68. Kissel H, Timokhina I, Hardy MP, Rothschild G, Tajima Y, Soares V, et al. Point mutation in kit receptor tyrosine kinase reveals essential roles for kit signaling in spermatogenesis and oogenesis without affecting other kit responses. EMBO J 2000; 19(6): 1312-1326.
69. Meng X, Lindahl M, Hyvonen ME, Parvinen M, de Rooij DG, Hess MW, et al. Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. Science 2000; 287(5457): 1489-1493.
70. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, et al. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 1996; 384(6608): 470-474.
71. Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 1996; 68: 67-108.
72. Beumer TL, Roepers-Gajadien HL, Gademan IS, Kal HB, de Rooij DG. Involvement of the D-type cyclins in germ cell proliferation and differentiation in the mouse. Biol Reprod 2000; 63(6): 1893-1898.
73. Venables JP, Ruggiu M, Cooke HJ. The RNA-binding specificity of the mouse Dazl protein. Nucleic Acids Res 2001; 29(12): 2479-2483.
74. Xu EY, Moore FL, Pera RA. A gene family required for human germ cell development evolved from an ancient meiotic gene conserved in metazoans. Proc Natl Acad Sci USA 2001; 98(13): 7414-7419.
75. Brekhman V, Itskovitz-Eldor J, Yodko E, Deutsch M, Seligman J. The DAZL1 gene is expressed in human male and female embryonic gonads before meiosis. Mol Hum Reprod 2000; 6(5): 465-468.
76. Ruggiu M, Speed R, Taggart M, McKay SJ, Kilanowski F, Saunders P, et al. The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. Nature 1997; 389(6646): 73-77.
77. Champion MD, Hawley RS. Playing for half the deck: the molecular biology of meiosis. Nat Cell Biol 2002; 4(Suppl): s50-56.
78. Kneitz B, Cohen PE, Avdievich E, Zhu L, Kane MF, Hou H Jr, et al. MutS homolog 4 localization to meiotic chromosomes is required for chromosome pairing during meiosis in male and female mice. Genes Dev 2000; 14(9): 1085-1097.
79. Edelmann W, Cohen PE, Kneitz B, Winand N, Lia M, Heyer J, et al. Mammalian MutS homologue 5 is required for chromosome pairing in meiosis. Nat Genet 1999; 21(1): 123-127.
80. Edelmann W, Cohen PE, Kane M, Lau K, Morrow B, Bennett S, et al. Meiotic pachytene arrest in MLH1-deficient mice. Cell 1996; 85(7): 1125-1134.
81. Baker SM, Bronner CE, Zhang L, Plug AW, Robatzek M, Warren G, et al. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell 1995; 82(2): 309-319.
82. Pittman DL, Cobb J, Schimenti KJ, Wilson LA, Cooper DM, Brignull E, et al. Meiotic prophase arrest with failure of chromosome synapsis in mice deficient for Dmc1, a germline-specific RecA homolog. Mol Cell 1998; 1(5): 697-705.
83. Yoshida K, Kondoh G, Matsuda Y, Habu T, Nishimune Y, Morita T. The mouse RecA-like gene Dmc1 is required for homologous chromosome synapsis during meiosis. Mol Cell 1998; 1(5): 707-718.
84. Mandon-Pepin B, Derbois C, Matsuda F, Cotinot C, Wolgemuth DJ, Smith K, et al. [Human infertility: meiotic genes as potential candidates]. Gynecol Obstet Fertil 2002; 30(10): 817-821.
85. Diaz RL, Alcid AD, Berger JM, Keeney S. Identification of residues in yeast Spo11p critical for meiotic DNA double-strand break formation. Mol Cell Biol 2002; 22(4): 1106-1115.
86. Romanienko PJ, Camerini-Otero RD. The mouse Spo11 gene is required for meiotic chromosome synapsis. Mol Cell 2000; 6(5): 975-987.
87. Baudat F, Manova K, Yuen JP, Jasin M, Keeney S. Chromosome synapsis defects and sexually dimorphic meiotic progression in mice lacking Spo11. Mol Cell 2000; 6(5): 989-998.
88. Schrader M, Muller-Tidow C, Ravnik S, Muller M, Schulze W, Diederichs S, et al. Cyclin A1 and gametogenesis in fertile and infertile patients: a potential new molecular diagnostic marker. Hum Reprod 2002; 17(9): 2338-2343.
89. Wolgemuth DJ, Laurion E, Lele KM. Regulation of the mitotic and meiotic cell cycles in the male germ line. Recent Prog Horm Res 2002; 57: 75-101.
90. Liu D, Matzuk MM, Sung WK, Guo Q, Wang P, Wolgemuth DJ. Cyclin A1 is required for meiosis in the male mouse. Nat Genet 1998; 20(4): 377-380.
91. Liu D, Liao C, Wolgemuth DJ. A role for cyclin A1 in the activation of MPF and G2-M transition during meiosis of male germ cells in mice. Dev Biol 2000; 224(2): 388-400.
92. Zindy F, den Besten W, Chen B, Rehg JE, Latres E, Barbacid M, et al. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d). Mol Cell Biol 2001; 21(9): 3244-3255.
93. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003; 3(3): 155-168.
94. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 1996; 86(1): 159-171.
95. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev 1996; 10(19): 2411-2422.
96. Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 2001; 276(45): 42462-42467.
97. Andegeko Y, Moyal L, Mittelman L, Tsarfaty I, Shiloh Y, Rotman G. Nuclear retention of ATM at sites of DNA double strand breaks. J Biol Chem 2001; 276(41): 38224-38230.
98. Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, Sedelnikova OA, et al. Genomic instability in mice lacking histone H2AX. Science 2002; 296(5569): 922-927.
99. Yuan L, Liu JG, Zhao J, Brundell E, Daneholt B, Hong C. The murine SCP3 gene is required for synaptonemal complex assembly, chromosome synapsis, and male fertility. Mol Cell 2000; 5(1): 73-83.
100. Kuroda M, Sok J, Webb L, Baechtold H, Urano F, Yin Y, et al. Male sterility and enhanced radiation sensitivity in TLS(-/-) mice. EMBO J 2000; 19(3): 453-462.
101. Escalier D. Genetic approach to male meiotic division deficiency: the human macronuclear spermatozoa. Mol Hum Reprod 2002; 8(1): 1-7.
102. Raymond CS, Murphy MW, O'Sullivan MG, Bardwell VJ, Zarkower D. Dmrt1, a gene related to worm and fly sexual regulators, is required for mammalian testis differentiation. Genes Dev 2000; 14(20): 2587-2595.
103. Ottolenghi C, McElreavey K. Deletions of 9p and the quest for a conserved mechanism of sex determination. Mol Genet Metab 2000; 71(1-2): 397-404.
104. Tourtellotte WG, Nagarajan R, Auyeung A, Mueller C, Milbrandt J. Infertility associated with incomplete spermatogenic arrest and oligozoospermia in Egr4-deficient mice. Development 1999; 126(22): 5061-5071.
105. Ward WS, Coffey DS. DNA packaging and organization in mammalian spermatozoa: comparison with somatic cells. Biol Reprod 1991; 44(4): 569-574.
106. Mills NC, Van NT, Means AR. Histones of rat testis chromatin during early postnatal development and their interactions with DNA. Biol Reprod 1977; 17(5):760-768.
107. Meetei AR, Ullas KS, Vasupradha V, Rao MR. Involvement of protein kinase A in the phosphorylation of spermatidal protein TP2 and its effect on DNA condensation. Biochemistry 2002; 41(1): 185-195.
108. Yu YE, Zhang Y, Unni E, Shirley CR, Deng JM, Russell LD, et al. Abnormal spermatogenesis and reduced fertility in transition nuclear protein 1-deficient mice. Proc Natl Acad Sci USA 2000; 97(9): 4683-4688.
109. Zhao M, Shirley CR, Yu YE, Mohapatra B, Zhang Y, Unni E, et al. Targeted disruption of the transition protein 2 gene affects sperm chromatin structure and reduces fertility in mice. Mol Cell Biol 2001; 21(21): 7243-7255.
110. Adham IM, Nayernia K, Burkhardt-Gottges E, Topaloglu O, Dixkens C, Holstein AF, et al. Teratozoospermia in mice lacking the transition protein 2 (Tnp2). Mol Hum Reprod 2001; 7(6): 513-520.
111. Kierszenbaum AL. Transition nuclear proteins during spermiogenesis: unrepaired DNA breaks not allowed. Mol Reprod Dev 2001; 58(4): 357-358.
112. Steger K, Failing K, Klonisch T, Behre HM, Manning M, Weidner W, et al. Round spermatids from infertile men exhibit decreased protamine-1 and -2 mRNA. Hum Reprod 2001; 16(4): 709-716.
113. Carrell DT, Liu L. Altered protamine 2 expression is uncommon in donors of known fertility, but common among men with poor fertilizing capacity, and may reflect other abnormalities of spermiogenesis. J Androl 2001; 22(4): 604-610.
114. Cho C, Willis WD, Goulding EH, Jung-Ha H, Choi YC, Hecht NB, et al. Haploinsufficiency of protamine-1 or -2 causes infertility in mice. Nat Genet 2001; 28(1): 82-86.
115. Wu JY, Ribar TJ, Cummings DE, Burton KA, McKnight GS, Means AR. Spermiogenesis and exchange of basic nuclear proteins are impaired in male germ cells lacking Camk4. Nat Genet 2000; 25(4): 448-452.
116. Xu X, Toselli PA, Russell LD, Seldin DC. Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit. Nat Genet 1999; 23(1): 118-121.
117. Sassone-Corsi P. Unique chromatin remodeling and transcriptional regulation in spermatogenesis. Science 2002; 296(5576): 2176-2178.
118. Blendy JA, Kaestner KH, Weinbauer GF, Nieschlag E, Schutz G. Severe impairment of spermatogenesis in mice lacking the CREM gene. Nature 1996; 380(6570): 162-165.
119. Nantel F, Monaco L, Foulkes NS, Masquilier D, LeMeur M, Henriksen K, et al. Spermiogenesis deficiency and germ-cell apoptosis in CREM-mutant mice. Nature 1996; 380(6570): 159-162.
120. Sassone-Corsi P. CREM: a master-switch regulating the balance between differentiation and apoptosis in male germ cells. Mol Reprod Dev 2000; 56(2 Suppl): 228-229.
121. Ha H, van Wijnen AJ, Hecht NB. Tissue-specific protein-DNA interactions of the mouse protamine 2 gene promoter. J Cell Biochem 1997; 64(1): 94-105.
122. Behr R, Weinbauer GF. CREM activator and repressor isoforms in human testis: sequence variations and inaccurate splicing during impaired spermatogenesis. Mol Hum Reprod 2000; 6(11): 967-972.
123. Deng W, Lin H. miwi, a murine homolog of piwi, encodes a cytoplasmic protein essential for spermatogenesis. Dev Cell 2002; 2(6): 819-830.
124. Koken MH, Hoogerbrugge JW, Jasper-Dekker I, de Wit J, Willemsen R, Roest HP, et al. Expression of the ubiquitin-conjugating DNA repair enzymes HHR6A and B suggests a role in spermatogenesis and chromatin modification. Dev Biol 1996; 173(1): 119-132.
125. Roest HP, van Klaveren J, de Wit J, van Gurp CG, Koken MH, Vermey M, et al. Inactivation of the HR6B ubiquitin-conjugating DNA repair enzyme in mice causes male sterility associated with chromatin modification. Cell 1996; 86(5): 799-810.
126. Martianov I, Fimia GM, Dierich A, Parvinen M, Sassone-Corsi P, Davidson I. Late arrest of spermiogenesis and germ cell apoptosis in mice lacking the TBP-like TLF/TRF2 gene. Mol Cell 2001; 7(3): 509-515.
127. Martianov I, Brancorsini S, Gansmuller A, Parvinen M, Davidson I, Sassone-Corsi P. Distinct functions of TBP and TLF/TRF2 during spermatogenesis: requirement of TLF for heterochromatic chromocenter formation in haploid round spermatids. Development 2002; 129(4): 945-955.
128. Wishart MJ, Dixon JE. The archetype STYX/dead-phosphatase complexes with a spermatid mRNA-binding protein and is essential for normal sperm production. Proc Natl Acad Sci USA 2002; 99(4): 2112-2117.
129. Levy S, Serre V, Hermo L, Robaire B. The effects of aging on the seminiferous epithelium and the blood-testis barrier of the Brown Norway rat. J Androl 1999; 20(3): 356-365.
130. Slavis SA, Scholz JN, Hewitt CW, Black KS, Campbell RS, Patel M, et al. The effects of testicular trauma on fertility in the Lewis rat and comparisons to isoimmunized recipients of syngeneic sperm. J Urol 1990; 143(3): 638-641.
131. Huang HF, Yang CS, Meyenhofer M, Gould S, Boccabella AV. Disruption of sustentacular (Sertoli) cell tight junctions and regression of spermatogenesis in vitamin-A-deficient rats. Acta Anat (Basel) 1988; 133(1): 10-15.
132. Syed V, Hecht NB. Disruption of germ cell-Sertoli cell interactions leads to spermatogenic defects. Mol Cell Endocrinol 2002; 186(2): 155-157.
133. Weinbauer GF, Wessels J. 'Paracrine' control of spermatogenesis. Andrologia 1999; 31(5): 249-262.
134. Achermann JC, Ozisik G, Meeks JJ, Jameson JL. Genetic causes of human reproductive disease. J Clin Endocrinol Metab 2002; 87(6): 2447-2454.
135. Moyle WR, Ramachandran J. Effect of LH on steroidogenesis and cyclic AMP accumulation in rat Leydig cell preparations and mouse tumor Leydig cells. Endocrinology 1973; 93(1): 127-134.
136. Ghadessy FJ, Lim J, Abdullah AA, Panet-Raymond V, Choo CK, Lumbroso R, et al. Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions. J Clin Invest 1999; 103(11): 1517-1525.
137. Carreau S, Bourguiba S, Lambard S, Galeraud-Denis I, Genissel C, Levallet J. Reproductive system: aromatase and estrogens. Mol Cell Endocrinol 2002; 193(1-2): 137-143.
138. Turner KJ, Macpherson S, Millar MR, McNeilly AS, Williams K, Cranfield M, et al. Development and validation of a new monoclonal antibody to mammalian aromatase. J Endocrinol 2002; 172(1): 21-30.
139. Robertson KM, O'Donnell L, Jones ME, Meachem SJ, Boon WC, Fisher CR, et al. Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. Proc Natl Acad Sci USA 1999; 96(14): 7986-7991.
140. Grumbach MM, Auchus RJ. Estrogen: consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab 1999; 84(12): 4677-4694.
141. Eddy EM, Washburn TF, Bunch DO, Goulding EH, Gladen BC, Lubahn DB, et al. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 1996; 137(11): 4796-4805.
142. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000; 127(19): 4277-4291.
143. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 1998; 95(26): 15677-15682.
144. Lecureuil C, Fontaine I, Crepieux P, Guillou F. Sertoli and granulosa cell-specific Cre recombinase activity in transgenic mice. Genesis 2002; 33(3): 114-118.
145. Lu Q, Gore M, Zhang Q, Camenisch T, Boast S, Casagranda F, et al. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature 1999; 398(6729): 723-728.
146. Kroft TL, Patterson J, Won Yoon J, Doglio L, Walterhouse DO, Iannaccone PM, et al. GLI1 localization in the germinal epithelial cells alternates between cytoplasm and nucleus: upregulation in transgenic mice blocks spermatogenesis in pachytene. Biol Reprod 2001; 65(6): 1663-1671.
147. Bitgood MJ, McMahon AP. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol 1995; 172(1): 126-138.
148. Pierucci-Alves F, Clark AM, Russell LD. A developmental study of the Desert hedgehog-null mouse testis. Biol Reprod 2001; 65(5): 1392-1402.
149. Bitgood MJ, Shen L, McMahon AP. Sertoli cell signaling by Desert hedgehog regulates the male germline. Curr Biol 1996; 6(3): 298-304.
150. Yao HH, Whoriskey W, Capel B. Desert Hedgehog/Patched 1 signaling specifies fetal Leydig cell fate in testis organogenesis. Genes Dev 2002; 16(11): 1433-1440.
151. Loveland KL, Schlatt S. Stem cell factor and c-kit in the mammalian testis: lessons originating from Mother Nature's gene knockouts. J Endocrinol 1997; 153(3): 337-344.
152. Marziali G, Lazzaro D, Sorrentino V. Binding of germ cells to mutant Sld Sertoli cells is defective and is rescued by expression of the transmembrane form of the c-kit ligand. Dev Biol 1993; 157(1): 182-190.
153. Rossi P, Dolci S, Albanesi C, Grimaldi P, Ricca R, Geremia R. Follicle-stimulating hormone induction of steel factor (SLF) mRNA in mouse Sertoli cells and stimulation of DNA synthesis in spermatogonia by soluble SLF. Dev Biol 1993; 155(1): 68-74.
154. Kastner P, Mark M, Leid M, Gansmuller A, Chin W, Grondona JM, et al. Abnormal spermatogenesis in RXR beta mutant mice. Genes Dev 1996; 10(1): 80-92.
155. Akama TO, Nakagawa H, Sugihara K, Narisawa S, Ohyama C, Nishimura S, et al. Germ cell survival through carbohydrate-mediated interaction with Sertoli cells. Science 2002; 295(5552): 124-127.
156. McLachlan RI, O'Donnell L, Meachem SJ, Stanton PG, de Kretser DM, Pratis K, et al. Identification of specific sites of hormonal regulation in spermatogenesis in rats, monkeys, and man. Recent Prog Horm Res 2002; 57: 149-179.
157. Kumar TR, Wang Y, Lu N, Matzuk MM. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet 1997; 15(2): 201-204.
158. Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M, et al. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA 1998; 95(23): 13612-13617.
159. Allan CM, Haywood M, Swaraj S, Spaliviero J, Koch A, Jimenez M, et al. A novel transgenic model to characterize the specific effects of follicle-stimulating hormone on gonadal physiology in the absence of luteinizing hormone actions. Endocrinology 2001; 142(6): 2213-2220.
160. Zhang D, Penttila TL, Morris PL, Teichmann M, Roeder RG. Spermiogenesis deficiency in mice lacking the Trf2 gene. Science 2001; 292(5519): 1153-1155.
161. Krishnamurthy H, Kumar KM, Joshi CV, Krishnamurthy HN, Moudgal RN, Sairam, MR. Alterations in sperm characteristics of follicle-stimulating hormone (FSH)-immunized men are similar to those of FSH-deprived infertile male bonnet monkeys. J Androl 2000; 21(2): 316-327.
162. de Kretser DM, Loveland KL, Meehan T, O'Bryan MK, Phillips DJ, Wreford NG. Inhibins, activins and follistatin: actions on the testis. Mol Cell Endocrinol 2001; 180(1-2): 87-92.
163. de Winter JP, Vanderstichele HM, Timmerman MA, Blok LJ, Themmen AP, de Jong FH. Activin is produced by rat Sertoli cells in vitro and can act as an autocrine regulator of Sertoli cell function. Endocrinology 1993; 132(3): 975-982.
164. Kumar TR, Varani S, Wreford NG, Telfer NM, de Kretser DM, Matzuk MM. Male reproductive phenotypes in double mutant mice lacking both FSHbeta and activin receptor IIA. Endocrinology 2001; 142(8):3512-3518.
165. Krishnamurthy H, Danilovich N, Morales CR, Sairam MR. Qualitative and quantitative decline in spermatogenesis of the follicle-stimulating hormone receptor knockout (FORKO) mouse. Biol Reprod 2000; 62(5): 1146-1159.
166. Matzuk MM, Kumar TR, Bradley A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 1995; 374(6520): 356-360.
167. Orth JM. The role of follicle-stimulating hormone in controlling Sertoli cell proliferation in testes of fetal rats. Endocrinology 1984; 115(4): 1248-1255.
168. Crepieux P, Marion S, Martinat N, Fafeur V, Vern YL, Kerboeuf D, et al. The ERK-dependent signalling is stage-specifically modulated by FSH, during primary Sertoli cell maturation. Oncogene 2001; 20(34): 4696-4709.
169. Huhtaniemi IT, Aittomaki K. Mutations of follicle-stimulating hormone and its receptor: effects on gonadal function. Eur J Endocrinol 1998; 138(5): 473-481.
170. Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi I. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol 2001; 15(1): 172-183.
171. Dieckmann KP, Skakkebaek NE. Carcinoma in situ of the testis: review of biological and clinical features. Int J Cancer 1999; 83(6): 815-822.
172. Chaganti RS, Houldsworth J. Genetics and biology of adult human male germ cell tumors. Cancer Res 2000; 60(6): 1475-1482.
173. Skakkebaek NE. Possible carcinoma-in-situ of the testis. Lancet 1972; 2(7776): 516-517.
174. Gondos B. Ultrastructure of developing and malignant germ cells. Eur Urol 1993; 23(1): 68-74; discussion 75.
175. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997; 337(4): 242-253.
176. Meng X, de Rooij DG, Westerdahl K, Saarma M, Sariola H. Promotion of seminomatous tumors by targeted overexpression of glial cell line-derived neurotrophic factor in mouse testis. Cancer Res 2001; 61(8): 3267-3271.
177. Tian Q, Frierson HF Jr, Krystal GW, Moskaluk CA. Activating c-kit gene mutations in human germ cell tumors. Am J Pathol 1999; 154(6): 1643-1647.
178. Sakuma Y, Sakurai S, Oguni S, Hironaka M, Saito K. Alterations of the c-kit gene in testicular germ cell tumors. Cancer Sci 2003; 94(6): 486-491.
179. Leroy X, Augusto D, Leteurtre E, Gosselin B. CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma. J Histochem. Cytochem 2002; 50(2): 283-285.
180. Qiao D, Zeeman AM, Deng W, Looijenga LH, Lin H. Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminomas. Oncogene 2002; 21(25): 3988-3999.
181. Mayer F, Stoop H, Scheffer GL, Scheper R, Oosterhuis JW, Looijenga LH, et al. Molecular determinants of treatment response in human germ cell tumors. Clin Cancer Res 2003; 9(2): 767-773.
182. Walt H, Oosterhuis JW, Stevens LC. Experimental testicular germ cell tumorigenesis in mouse strains with and without spontaneous tumours differs from development of germ cell tumours of the adult human testis. Int J Androl 1993; 16(4): 267-271.
183. Langley RE, Palayoor ST, Coleman CN, Bump EA. Radiation-induced apoptosis in F9 teratocarcinoma cells. Int J Radiat Biol 1994; 65(5): 605-610.
184. Jones RH, Vasey PA. New directions in testicular cancer; molecular determinants of oncogenesis and treatment success. Eur J Cancer 2003; 39(2): 147-156.
185. Ginsberg D, Mechta F, Yaniv M, Oren M. Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci USA 1991; 88(22): 9979-9983.
186. Stevens LC. The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Dev Biol 1970; 21(3): 364-382.
187. Schmid P, Lorenz A, Hameister H, Montenarh M. Expression of p53 during mouse embryogenesis. Development 1991; 113(3): 857-865.
188. Nicol CJ, Harrison ML, Laposa RR, Gimelshtein IL, Wells PG. A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat Genet 1995; 10(2): 181-187.
189. Norimura T, Nomoto S, Katsuki M, Gondo Y, Kondo S. p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nat Med 1996; 2(5): 577-580.
190. Lutzker SG, Levine AJ. A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nat Med 1996; 2(7): 804-810.
191. Ashcroft M, Vousden KH. Regulation of p53 stability. Oncogene 1999; 18(53): 7637-7643.
192. Eid H, Institoris E, Geczi L, Bodrogi I, Bak M. mdm-2 expression in human testicular germ-cell tumors and its clinical value. Anticancer Res 1999; 19(4C): 3485-3490.
193. Datta MW, Macri E, Signoretti S, Renshaw AA, Loda M. Transition from in situ to invasive testicular germ cell neoplasia is associated with the loss of p21 and gain of mdm-2 expression. Mod Pathol 2001; 14(5): 437-442.
194. Houldsworth J, Xiao H, Murty VV, Chen W, Ray B, Reuter VE, et al. Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation. Oncogene 1998; 16(18): 2345-2349.
195. Korsmeyer SJ. Regulators of cell death. Trends Genet 1995; 11(3): 101-105.
196. Chresta CM, Masters JR, Hickman JA. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax: Bcl-2 ratio. Cancer Res 1996; 56(8): 1834-1841.
197. Kimura T, Suzuki A, Fujita Y, Yomogida K, Lomeli H, Asada N, et al. Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development 2003; 130(8): 1691-1700.
198. Stokoe D. Pten. Curr Biol 2001; 11(13): R502.
199. Lutzker SG, Barnard NJ. Testicular germ cell tumors: molecular understanding and clinical implications. Mol Med Today 1998; 4(9): 404-411.
200. Bosl GJ, Ilson DH, Rodriguez E, Motzer RJ, Reuter VE, Chaganti RS. Clinical relevance of the i(12p) marker chromosome in germ cell tumors. J Natl Cancer Inst 1994; 86(5): 349-355.
201. Atkin NB, Baker MC. Chromosome analysis of three seminomas. Cancer Genet Cytogenet 1985; 17(4): 315-323.
202. Houldsworth J, Reuter V, Bosl GJ, Chaganti RS. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Cell Growth Differ 1997; 8(3): 293-299.
203. Muller-Tidow C, Diederichs S, Schrader MG, Vogt U, Miller K, Berdel WE, et al. Cyclin A1 is highly expressed in aggressive testicular germ cell tumors. Cancer Lett 2003; 190(1): 89-95.
204. Zindy F, van Deursen J, Grosveld G, Sherr CJ, Roussel MF. INK4d-deficient mice are fertile despite testicular atrophy. Mol Cell Biol 2000; 20(1): 372-378.
205. Bartkova J, Thullberg M, Rajpert-De Meyts E, Skakkebaek NE, Bartek J. Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis. Oncogene 2000; 19(36): 4146-4150.
206. Bartkova J, Thullberg M, Rajpert-De Meyts E, Skakkebaek NE, Bartek J. Cell cycle regulators in testicular cancer: loss of p18INK4C marks progression from carcinoma in situ to invasive germ cell tumours. Int J Cancer 2000; 85(3): 370-375.
207. Lundberg AS, Weinberg RA. Control of the cell cycle and apoptosis. Eur J Cancer 1999; 35(4): 531-539.
208. Yan W, Kero J, Suominen J, Toppari J. Differential expression and regulation of the retinoblastoma family of proteins during testicular development and spermatogenesis: roles in the control of germ cell proliferation, differentiation and apoptosis. Oncogene 2001; 20(11): 1343-1356.
209. Strohmeyer T, Reissmann P, Cordon-Cardo C, Hartmann M, Ackermann R, Slamon D. Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc Natl Acad Sci USA 1991; 88(15): 6662-6666.
210. Mayer F, Gillis AJ, Dinjens W, Oosterhuis JW, Bokemeyer C, Looijenga LH. Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment. Cancer Res 2002; 62(10): 2758-2760.
211. Koberle B, Masters JR, Hartley JA, Wood RD. Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours. Curr Biol 1999; 9(5): 273-276.
212. Robertson KA, Bullock HA, Xu Y, Tritt R, Zimmerman E, Ulbright TM, et al. Altered expression of Apel/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res 2001; 61(5): 2220-2225.
213. Moroni M, Veronese S, Schiavo R, Carminati O, Sorensen BS, Gambacorta M, et al. Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors. Clin Cancer Res 2001; 7(9): 2770-2775.
214. Summersgill B, Goker H, Weber-Hall S, Huddart R, Horwich A, Shipley J. Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change. Br J Cancer 1998; 77(2): 305-313.
215. Carpenter D, Stone DM, Brush J, Ryan A, Armanini M, Frantz G, et al. Characterization of two patched receptors for the vertebrate hedgehog protein family. Proc Natl Acad Sci USA 1998; 95(23): 13630-13634.
216. Cooke HJ, Saunders PT. Mouse models of male infertility. Nat Rev Genet 2002; 3(10): 790-801.
217. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993; 341(8857): 1392-1395.
218. Goldenberg MM. Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer. Clin Ther 1999; 21(2): 309-318.
219. Swain A, Lovell-Badge R. A molecular approach to sex determination in mammals. Acta Paediatr Suppl 1997; 423: 46-49.
220. Luo X, Ikeda Y, Parker KL. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994; 77(4): 481-490.
221. Anderson R, Fassler R, Georges-Labouesse E, Hynes RO, Bader BL, Kreidberg JA, et al. Mouse primordial germ cells lacking betal integrins enter the germline but fail to migrate normally to the gonads. Development 1999; 126(8): 1655-1664.
222. Juneja SC, Barr KJ, Enders GC, Kidder GM. Defects in the germ line and gonads of mice lacking connexin43. Biol Reprod 1999; 60(5): 1263-1270.
223. Luoh SW, Bain PA, Polakiewicz RD, Goodheart ML, Gardner H, Jaenisch R, et al. Zfx mutation results in small animal size and reduced germ cell number in male and female mice. Development 1997; 124(11): 2275-2284.
224. Matsui Y, Nagano R, Obinata M. Apoptosis of fetal testicular cells is regulated by both p53-dependent and independent mechanisms. Mol Reprod Dev 2000; 55(4): 399-405.
225. Honarpour N, Du C, Richardson JA, Hammer RE, Wang X, Herz J. Adult Apaf-1-deficient mice exhibit male infertility. Dev Biol 2000; 218(2): 248-258.
226. Knudson CM, Korsmeyer SJ. Bcl-2 and Bax function independently to regulate cell death. Nat Genet 1997; 16(4): 358-363.
227. Lee HW, Blasco MA, Gottlieb GJ, Horner JW 2nd, Greider CW, DePinho RA. Essential role of mouse telomerase in highly proliferative organs. Nature 1998; 392(6676): 569-574.
228. Boettger-Tong HL, Johnston DS, Russell LD, Griswold MD, Bishop CE. Juvenile spermatogonial depletion (jsd) mutant seminiferous tubules are capable of supporting transplanted spermatogenesis. Biol Reprod 2000; 63(4): 1185-1191.
229. Barlow C, Liyanage M, Moens PB, Tarsounas M, Nagashima K, Brown K, et al. Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I. Development 1998; 125(20): 4007-4017.
230. Nakai A, Suzuki M, Tanabe M. Arrest of spermatogenesis in mice expressing an active heat shock transcription factor 1. EMBO J 2000; 19(7): 1545-1554.
231. Lipkin SM, Moens PB, Wang V, Lenzi M, Shanmugarajah D, Gilgeous A, Thomas J, Cheng J, Touchman JW, Green ED, Schwartzberg P, Collins FS, Cohen PE. Meiotic arrest and aneuploidy in MLH3-deficient mice. Nat Genet 2002; 31(4): 385-390.
232. Nef S, Parada LF. Cryptorchidism in mice mutant for Ins13. Nat Genet 1999; 22(3): 295-299.
233. Gow A, Southwood CM, Li JS, Pariali M, Riordan GP, Brodie SE, et al. CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin- 11 null mice. Cell 1999; 99(6): 649-659.
234. Gnessi L, Basciani S, Mariani S, Arizzi M, Spera G, Wang C, et al. Leydig cell loss and spermatogenic arrest in platelet-derived growth factor (PDGF)-A-deficient mice. J Cell Biol 2000; 149(5): 1019-1026.
235. Varmuza S, Jurisicova A, Okano K, Hudson J, Boekelheide K, Shipp EB. Spermiogenesis is impaired in mice bearing a targeted mutation in the protein phosphatase 1cgamma gene. Dev Biol 1999; 205(1): 98-110.
236. Zhong J, Peters AH, Lee K, Braun RE. A double-stranded RNA binding protein required for activation of repressed messages in mammalian germ cells. Nat Genet 1999; 22(2): 171-174.
237. Komada M, McLean DJ, Griswold MD, Russell LD, Soriano P. E-MAP-115, encoding a microtubule-associated protein, is a retinoic acid-inducible gene required for spermatogenesis. Genes Dev 2000; 14(11): 1332-1342.
238. Thepot D, Weitzman JB, Barra J, Segretain D, Stinnakre MG, Babinet C, et al. Targeted disruption of the murine junD gene results in multiple defects in male reproductive function. Development 2000; 127(1): 143-153.
239. Fisher CR, Graves KH, Parlow AF, Simpson ER. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci USA 1998; 95(12): 6965-6970.
240. Pace AJ, Lee E, Athirakul K, Coffman TM, O'Brien DA, Koller BH. Failure of spermatogenesis in mouse lines deficient in the Na(+)-K(+)-2Cl(-) cotransporter. J Clin Invest 2000; 105(4): 441-450.
241. Bouchard MJ, Dong Y, McDermott BM Jr, Lam DH, Brown KR, Shelanski M, et al. Defects in nuclear and cytoskeletal morphology and mitochondrial localization in spermatozoa of mice lacking nectin-2, a component of cell-cell adherens junctions. Mol Cell Biol 2000; 20(8): 2865-2873.
242. Yanaka N, Kobayashi K, Wakimoto K, Yamada E, Imahie H, Imai Y, et al. Insertional mutation of the murine kisimo locus caused a defect in spermatogenesis. J Biol Chem 2000; 275(20): 14791-14794.
243. Yeung CH, Wagenfeld A, Nieschlag E, Cooper TG. The cause of infertility of male c-ros tyrosine kinase receptor knockout mice. Biol Reprod 2000; 63(2): 612-618.
244. Yu RN, Ito M, Saunders TL, Camper SA, Jameson JL. Role of Ahch in gonadal development and gametogenesis. Nat Genet 1998; 20(4): 353-357.
245. Tajima Y, Onoue H, Kitamura Y, Nishimune Y. Biologically active kit ligand growth factor is produced by mouse Sertoli cells and is defective in SId mutant mice. Development 1991; 113(3): 1031-1035.
246. Hess RA, Bunick D, Lee KH, Bahr J, Taylor JA, Korach KS, et al. A role for oestrogens in the male reproductive system. Nature 1997; 390(6659): 509-512.
247. Chandrashekar V, Bartke A, Awoniyi CA, Tsai-Morris CH, Dufau ML, Russell LD, et al. Testicular endocrine function in GH receptor gene disrupted mice. Endocrinology 2001; 142(8): 3443-3450.
248. Osuga J, Ishibashi S, Oka T, Yagyu H, Tozawa R, Fujimoto A, et al. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci USA 2000; 97(2): 787-792.
249. Jeyaraj DA, Grossman G, Weaver C, Petrusz P. Dynamics of testicular germ cell proliferation in normal mice and transgenic mice overexpressing rat androgen-binding protein: a flow cytometric evaluation. Biol Reprod 2002; 66(4): 877-885.
250. Weiss RE, Xu J, Ning G, Pohlenz J, O'Malley BW, Refetoff S. Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. EMBO J 1999; 18(7): 1900-1904.
251. Grobholz R, Zentgraf H, Kohrmann KU, Bleyl U. Bax, Bcl-2, fas and Fas-L antigen expression in human seminoma: correlation with the apoptotic index. APMIS 2002; 110(10): 724-732.
252. Atkin NB, Baker MC. One or two double minutes in three carcinomas. Cancer Genet Cytogenet 1987; 25(1): 189-190.
253. Rajpert-De Meyts E, Jacobsen GK, Bartkova J, Aubry F, Samson M, Bartek J, et al. The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE-A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminoma. Histopathology 2003; 42(3): 217-226.
254. Elba S, Buongiorno GP, Caruso ML, Noviello MR, Manghisi OG. Main characteristics of hepatocellular carcinoma and cirrhosis and therapeutic approaches. Curr Pharm Design 2002; 8(11): 1007-11.
255. Filshie RJ. Cytokines in haemopoietic progenitor mobilisation for peripheral blood stem cell transplantation. Curr Pharm Design 2002; 8(5): 379-94.
256. Hackney AC. Endurance exercise training and reproductive endocrine dysfunction in men: alterations in the hypothalamic-pituitary-testicular axis. Curr Pharm Design 2001; 7(4): 261-73.